As the new cases and related deaths fall in sub-Saharan Africa, the virus is rearing its head elsewhere. What's the cause?
Speaking at the 16th International Aids Conference in 2006, the then UNAids executive director, Peter Piot, remarked: "Since ...
Merck's experimental two-drug combination met the main goal of significantly suppressing replication of the HIV-1 virus in ...
A recent study showed that rates of antiretroviral therapy in enrollees living with HIV increased over the years, but women ...
Gilead Sciences will no longer provide four HIV medicines for free as part of a patient assistance program starting at the ...
A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global ...
As we mark the holidays, here are a few of the many heroes who are working to build a stronger global health future by ...
Introduced in Malawi in 2015, the HeForShe initiative engages men and boys as allies in dismantling patriarchal norms and ...
The prevalence of HPV81 in mother-child pairs with HIV in Nigeria could have implications on vaccination against human ...
Darwin Tenoria first learned about HIV when he was on his deathbed. He was 27 and weighed just 70 pounds. "I died for two minutes and I was revived in the hospital," he remembers. When he woke up ...